OSL was mentioned last night on YMYC.
As a additional company when panel were asked about CSL & Sirtex.
With CSL being the standout in the health space,
And good words on Sirtex,
regarding management, numbers of centres now using Srx and margin.
Although the treatment is a late in cancer event, and used to extend life for a period.
Whereas Oncocil, is an earlier treatment in the cycle,
implying some ability to possibly cure.
A company with good management, and enormous growth prospects.
I think OSL, could be very disruptive to the Srx treatment option,
Once OSL get Approvals and subsequent numbers of centres using the treatment.
And with the recent employment by OSL of ex Sirtex management,
Seems like I'm not the only one
With the recent strength of the share price, constant buying up ways.
And holding up so well in the massive sell off of other stocks.
It looks to me as it news is brewing. And perhaps some behind the scenes action happening.
Very happy to own stock in OSL, and looking forward to a very big upgrade in value this year.
OSL Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)